NASDAQ: TPSTTempest Therapeutics Inc Stock Ownership - Who owns Tempest Therapeutics?
Insider buying vs selling
Have Tempest Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when TPST insiders and whales buy or sell their stock.
TPST Shareholders
What type of owners hold Tempest Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Matthew Angel | 186.22% | 8,268,495 | $19.51M | Insider |
| Michelle Dipp | 179.25% | 7,959,182 | $18.78M | Insider |
| Richard Aldrich | 117.45% | 5,214,762 | $12.31M | Insider |
| Christoph H. Westphal | 101.96% | 4,527,348 | $10.68M | Insider |
| Versant Venture Capital VI LP | 78.98% | 3,507,056 | $8.28M | Insider |
| Bessemer Venture Partners VII LP | 53.87% | 2,392,034 | $5.65M | Insider |
| Thomas Woiwode | 49.18% | 2,183,788 | $5.15M | Insider |
| Versant Vantage II LP | 47.72% | 2,118,644 | $5.00M | Insider |
| Longwood Fund LP | 41.43% | 1,839,689 | $4.34M | Insider |
| David M. Mott | 39.78% | 1,766,407 | $4.17M | Insider |
TPST vs Biotech Stocks
Tempest Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.